TP53 and malignant colon neoplasm: The methylation levels of MORC1 in stages I, II, III, N0, N1, and N2, different molecular subtypes of colon cancer, TP53 mutation, TP53 wild-type, and normal colon tissues were all significantly different (P < 0.05) (Fig. 8a).